Recently adopted names for antitumoral compounds (February 2012) - Noms d’antitumoraux adoptés récemment (février 2012)

Name (nom)	Code name	Type	Target(s)
balugrastim	CG-10639	Fusion protein	G-CSF
firtecan pegol	EZN-2208, PEG-SN38	Synthetic small molecule conjugate prodrug	Topoisomerase I
ibrutinib	PCI-32765, CRA-032765, PCI-32765-00	Synthetic small molecule	Bruton tyrosine kinase
momelotinib	CYT-387	Synthetic small molecule	JAK1 & JAK2
oprozomib	ONX-0912	Synthetic small molecule	Proteasome
nivolumab	MDX-1106, BMS-936558	Monoclonal antibody	Programmed Death-1
quisinostat	JNJ-26481585	Synthetic small molecule	HDAC
saridegib	IPI-926, FIN-5	Natural product-derived small molecule	Smoothened (Smo)
technetium Tc 99m etarfolatide	EC-20	Synthetic small molecule	Folate receptor
vocimagene amiretrorepvec	TOCA-511	Viral vector

More on ibrutinib:

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919935/pdf/pnas.201004594.pdf

More on momelotinib:

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2892953/?tool=pubmed

More on oprozomib:

http://bloodjournal.hematologylibrary.org/content/116/23/4906.full.pdf+html

More on quisinostat:

http://clincancerres.aacrjournals.org/content/15/22/6841.full.pdf+html

More on saridegib:

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998180/pdf/nihms228663.pdf

More on vocimagene amiretrorepvec:

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266384/?tool=pubmed